Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement

Conflicto de intereses en la práctica clínica: Análisis ético de algunas relaciones con la industria

“…comerciales que pueden involucrar conflictos de intereses 22 . Entre ellas, se mencionan las visitas de representantes médicos a consultas y hospitales, la aceptación de regalos directos como equipos, viajes o acomodaciones en hoteles, o regalos indirectos a través de apoyo en la adquisición de equipos computacionales o viajes a conferencias, participación en comidas o eventos recreacionales o educacionales organizados por las compañías comerciales, compra de acciones de compañías farmacéuticas, conducción de ensayos clínicos o participación en la confección de guías clínicas o artículos de opinión financiados por la industria, aceptación de pagos por consultorías técnicas a determinadas compañías, ser miembro de consejos asesores de la industria farmacéutica, etc.…”

The pharmaceutical industry, researchers and publishers: the realities of competing interests within specialty journals

“…3 I commissioned the article in question after hearing the first author present his experiences with using the drug -experience that would not have been possible without assistance from the manufacturer. Selecting peer reviewers was tricky because those that knew the drug well were also in some way linked to the manufacturer.…”

“…Each of these strategies is strengthened -either directly by the pharmaceutical company or through public relations agencies -by using respected opinion leaders to front them. 3,8,9,11 By relaying their messages through established scientists and clinicians the pharmaceutical industry is able to gain credibility. Sometimes the opinion leaders do not write the articles themselves, but merely approve the text supplied by the manufacturer.…”

Pharmaceutical representatives’ beliefs and practices about their professional practice: a study in Sudan

“…They are an important promotional tool for pharmaceutical companies and the influence of sales representatives on doctors' prescribing behaviour is well documented in the literature [3][4][5][6][7][8][9][10][11]. Watkins et al found that doctors who have frequent contact with pharmaceutical representatives are usually more willing to prescribe new drugs and tend not to end consultations with just advice to patients [11].…”

“…Watkins et al found that doctors who have frequent contact with pharmaceutical representatives are usually more willing to prescribe new drugs and tend not to end consultations with just advice to patients [11]. Studies from several countries showed that 80% to 90% of doctors regularly see pharmaceutical representatives despite evidence that their information is overly positive and doctors' prescribing habits are less appropriate as a result [6][7][8][9][10]. There are others concerns too about biased or even false information.…”